TennesseeDrugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Apr 28Comp. became Pub. Ch. 206Latest
- Mar 31Companion House Bill substitutedMajor
- Mar 28Placed on Senate Regular Calendar for 3/31/2025
- Mar 25Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
- Vote recorded SENATE COMMERCE AND LABOR COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/25/2025 Passed. Result: pass.Upper
- Mar 19Placed on Senate Commerce and Labor Committee calendar for 3/25/2025
- Mar 18Action deferred in Senate Commerce and Labor Committee to 3/25/2025
- Mar 13Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
- Mar 11Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
- Feb 12Passed on Second Consideration, refer to Senate Commerce and Labor CommitteeMinor
- Feb 10Introduced, Passed on First ConsiderationMinor
- Jan 28Filed for introductionIntroduced